Related Experiment Video
Updated: May 18, 2026
06:40
Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
Fluorogenic quantum dot-gold nanoparticle assembly for beta secretase inhibitor screening in live cell
Youngseon Choi1, Yoojin Cho, Minjung Kim
1Medicinal Chemistry Laboratory, Institut Pasteur Korea (IP-K), 696 Sampyeong-dong, Bundang-gu, Seongnam-Si, Gyeonggi-Do, 464-400, South Korea.
Analytical Chemistry
|September 8, 2012
Summary
Researchers created a novel quantum dot-gold nanoparticle probe to detect beta-secretase 1 (BACE1) activity. This probe enables visualization of BACE1 in cells and supports high-throughput screening for Alzheimer's disease drugs.
Area of Science:
- Nanotechnology
- Biochemistry
- Biophysics
Background:
- Beta-secretase 1 (BACE1) is a key enzyme in amyloid-beta production, implicated in Alzheimer's disease pathogenesis.
- Developing sensitive and specific probes for BACE1 activity is crucial for disease understanding and drug discovery.
Purpose of the Study:
- To develop a novel fluorogenic nanoprobe for real-time detection and quantification of BACE1 activity.
- To validate the probe's efficacy in vitro and in living cells for high-throughput screening applications.
Main Methods:
- Assembly of cadmium selenide/zinc sulfide (CdSe/ZnS) quantum dots (QDs) with gold nanoparticles (AuNPs) via Ni-nitrilotriacetate (Ni-NTA) and histidine (His) interaction.
- Utilized fluorescence resonance energy transfer (FRET) for efficient quenching of QD fluorescence.
- Demonstrated fluorescence recovery upon BACE1 enzymatic cleavage of a conjugated substrate peptide.
Main Results:
- The QD-AuNP nanoprobe exhibited high fluorescence quenching efficiency.
- Successful visualization of BACE1 activity in living cells was achieved.
- The system allowed for the determination of half maximal inhibitory concentration (IC50) values for BACE1 inhibitors in a high-throughput screening (HTS) assay.
Conclusions:
- The developed QD-AuNP assembly serves as a robust and efficient probe for BACE1 activity.
- This nanoprobe has significant potential for high-throughput drug screening systems targeting BACE1-related diseases like Alzheimer's disease.
